Overview
🌐 Website: curocom.com
💲 Revenue:
📍 Address: Korea
👥 Employees:
🗓️ Established: 1997
📅 Published: December 20, 2014
✏️ Last updated: December 17, 2025
크레오에스지 (CreoSG) (CUROCOM)
AskAI Summary of 크레오에스지 (CreoSG) (CUROCOM)
Generated using ISVWorld's AskAI proprietary software industry model.
📝 AskAI Recap: CreoSG (크레오에스지) is a biotechnology company involved in developing vaccine platform technologies, including recombinant VSV vector systems and COVID-19 vaccines, holding multiple patents and progressing through clinical trials.
💬 Inclusion Rationale: Based on the page content, CreoSG is actively involved in developing proprietary vaccine software platforms and technologies such as recombinant VSV vector system, filing patents, and developing vaccine products as software-enabled bio solutions. This indicates they develop and sell proprietary software products related to biotech and vaccine development, qualifying them as an ISV rather than purely a research or hardware company.
Contacts
Access available business contacts and professional information associated with 크레오에스지 (CreoSG) (CUROCOM) through the interactive ISVWorld profile.
Similar Companies
Explore companies similar to 크레오에스지 (CreoSG) (CUROCOM) based on software focus, industries, technologies, and market positioning.
Classifications
Company Tags
External Profiles
Scores
Company News
View the latest company news, product announcements, partnerships, and business developments related to 크레오에스지 (CreoSG) (CUROCOM).
Relevant Industry News
Explore market and industry news relevant to 크레오에스지 (CreoSG) (CUROCOM) and its software categories.
Funding
Review available funding rounds, investors, acquisitions, and financing activity associated with 크레오에스지 (CreoSG) (CUROCOM).
